Rowland Thomas Andrew 4
4 · VENTRUS BIOSCIENCES INC · Filed Jan 18, 2012
Insider Transaction Report
Form 4
Rowland Thomas Andrew
Director
Transactions
- Award
Stock Options (Right to Buy)
2012-01-15+30,000→ 30,000 totalExercise: $8.10From: 2013-01-15Exp: 2021-01-25→ Common Stock (30,000 underlying)
Holdings
- 250,000
Stock Options (Right to Buy)
Exercise: $6.42Exp: 2021-01-25→ Common Stock (250,000 underlying) - 35,000
Stock Options (Right to Buy)
Exercise: $6.00Exp: 2020-11-10→ Common Stock (35,000 underlying) - 18,387
Common Stock
Footnotes (3)
- [F1]The options vest 1/3 on 1/15/2013, and the remaining 2/3 will vest in equal installments on the first and second anniversaries after 1/15/2013.
- [F2]The options vested 1/3 on 1/25/2011, and the remaining 2/3 will vest in equal installments on the first and second anniversaries after 1/25/2011.
- [F3]The options vested 1/3 on 3/1/2009, and the remaining 2/3 will vest in equal installments on the first and second anniversaries after 3/1/2009.